Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MJNE
|
Terrence Mcgill Tierney
President |
BUY
Open market or private purchase
|
Direct | 250 Added 0.07% |
$43
$0.17 p/Share
|
Mar 16
2020 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 0 Reduced 0.0% |
-
|
Mar 16
2020 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct | 3,455,129 Reduced 11.65% |
-
|
Mar 16
2020 |
IMRA
|
Rock Springs Capital Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 32.32% |
$4,000,000
$16.0 p/Share
|
Mar 16
2020 |
IMRA
|
Rock Springs Capital Management LP
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 273,411 Added 50.0% |
-
|
Mar 16
2020 |
MKL
|
Debora J Wilson
Director |
BUY
Other acquisition or disposition
|
Direct | 9 Added 0.3% |
$8,599
$955.46 p/Share
|
Mar 16
2020 |
AXS
|
Albert Benchimol
President and CEO |
BUY
Open market or private purchase
|
Direct | 2,704 Added 0.49% |
$101,400
$37.5 p/Share
|
Mar 16
2020 |
IMRA
|
Pfizer Inc
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,169,219 Added 35.23% |
-
|
Mar 16
2020 |
IMRA
|
Pfizer Inc
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 76,003 Added 50.0% |
-
|
Mar 16
2020 |
IMRA
|
Pfizer Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 312,500 Added 17.42% |
$5,000,000
$16.0 p/Share
|
Mar 16
2020 |
RILY
|
Andrew Moore
CEO B. Riley Securities, Inc. |
BUY
Open market or private purchase
|
Direct | 6,000 Added 4.12% |
$108,480
$18.08 p/Share
|
Mar 16
2020 |
CRM
|
Craig Conway
Director |
SELL
Open market or private sale
|
Direct | 225 Reduced 2.17% |
$29,475
$131.0 p/Share
|
Mar 16
2020 |
IBCP
|
Christina Keller
Director |
BUY
Open market or private purchase
|
Indirect | 1,267 Added 29.33% |
$17,903
$14.13 p/Share
|
Mar 16
2020 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 4,650 Added 0.34% |
$32,690
$7.03 p/Share
|
Mar 16
2020 |
CZNC
|
J Bradley Scovill
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.91% |
$9,375
$18.75 p/Share
|
Mar 16
2020 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.03% |
$1,328,700
$132.87 p/Share
|
Mar 16
2020 |
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Mar 16
2020 |
IMRA
|
Orbimed Advisors LLC
Director |
BUY
Conversion of derivative security
|
Indirect | 1,594,902 Added 38.64% |
-
|
Mar 16
2020 |
ASPS
|
Deer Park Road Management Company, LP |
BUY
Open market or private purchase
|
Indirect | 96,653 Added 2.79% |
$836,048
$8.65 p/Share
|
Mar 16
2020 |
AWR
|
Paul J Rowley
SVP OF OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct | 187 Reduced 4.47% |
$16,218
$86.73 p/Share
|
Mar 15
2020 |
QSR
|
Axel Mr Schwan
Pres., Tim Hortons Americas |
SELL
Open market or private sale
|
Direct | 37,854 Reduced 63.73% |
$2,368,903
$62.58 p/Share
|
Mar 15
2020 |
QSR
|
Axel Mr Schwan
Pres., Tim Hortons Americas |
BUY
Exercise of conversion of derivative security
|
Direct | 44,218 Added 42.68% |
$1,868,653
$42.26 p/Share
|
Mar 15
2020 |
NMIH
|
Julie Norberg
SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,062 Added 26.13% |
-
|
Mar 15
2020 |
GABC
|
Mark A Schroeder
EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct | 3,528 Added 2.82% |
-
|
Mar 15
2020 |
GABC
|
Clay W Ewing
EXECUTIVE VICE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct | 2,002 Added 2.11% |
-
|
Mar 15
2020 |
GABC
|
Bradley M Rust
PRESIDENT & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 1,552 Added 4.72% |
-
|
Mar 15
2020 |
GABC
|
Randall L. Braun
EVP, CHIEF BANKING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,158 Added 6.32% |
-
|
Mar 15
2020 |
GABC
|
Keith A. Leinenbach
EVP, CHIEF CREDIT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,192 Added 2.9% |
-
|
Mar 15
2020 |
GABC
|
D Neil Dauby
CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 1,158 Added 6.01% |
-
|
Mar 15
2020 |
CNA
|
Albert Joseph Miralles Jr
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,749 Reduced 9.91% |
$198,858
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Albert Joseph Miralles Jr
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,205 Added 18.54% |
-
|
Mar 15
2020 |
CNA
|
Elizabeth Ann Aguinaga
EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,292 Reduced 4.61% |
$44,690
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Elizabeth Ann Aguinaga
EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,203 Added 26.69% |
-
|
Mar 15
2020 |
CNA
|
Dino Robusto
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 51,749 Reduced 13.61% |
$1,789,998
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Dino Robusto
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 108,049 Added 22.13% |
-
|
Mar 15
2020 |
CNA
|
Larry A. Haefner
EVP & Chief Actuary |
SELL
Payment of exercise price or tax liability
|
Direct | 3,696 Reduced 6.06% |
$127,845
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Larry A. Haefner
EVP & Chief Actuary |
BUY
Grant, award, or other acquisition
|
Direct | 9,903 Added 13.96% |
-
|
Mar 15
2020 |
CNA
|
Michael Anthony Costonis
EVP, Head of Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 15,366 Added 24.23% |
-
|
Mar 15
2020 |
CNA
|
Douglas Worman
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,278 Reduced 14.07% |
$286,336
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Douglas Worman
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 24,490 Added 29.39% |
-
|
Mar 15
2020 |
CNA
|
Kevin James Leidwinger
President & COO, Commerical |
SELL
Payment of exercise price or tax liability
|
Direct | 9,559 Reduced 10.78% |
$330,646
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Kevin James Leidwinger
President & COO, Commerical |
BUY
Grant, award, or other acquisition
|
Direct | 23,950 Added 21.27% |
-
|
Mar 15
2020 |
CNA
|
David John Brosnan
President, International |
SELL
Payment of exercise price or tax liability
|
Direct | 7,014 Reduced 11.42% |
$242,614
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
David John Brosnan
President, International |
BUY
Grant, award, or other acquisition
|
Direct | 14,646 Added 19.26% |
-
|
Mar 15
2020 |
CNA
|
James Michael Anderson
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,299 Reduced 5.5% |
$79,522
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Kevin Gene Smith
President & COO, Specialty |
SELL
Payment of exercise price or tax liability
|
Direct | 5,446 Reduced 8.59% |
$188,377
$34.59 p/Share
|
Mar 15
2020 |
CNA
|
Kevin Gene Smith
President & COO, Specialty |
BUY
Grant, award, or other acquisition
|
Direct | 23,409 Added 26.96% |
-
|
Mar 15
2020 |
CNA
|
Jose Ramon Gonzalez
EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 5,109 Added 33.18% |
-
|
Mar 15
2020 |
UVSP
|
Duane J Brobst
Sr EVP & Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 98 Reduced 0.25% |
$1,772
$18.08 p/Share
|
Mar 15
2020 |
UVSP
|
Duane J Brobst
Sr EVP & Chief Credit Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 350 Added 0.89% |
-
|
Mar 15
2020 |